Skip to main content
. 2018 May;14(5):280–285.

Figure 1.

Figure 1.

The sustained virologic response rates of direct-acting antiviral regimens in patients with chronic kidney disease (stage 4 or 5).23,25 The ratios represent the cured patients of the total number of patients with combined stage 4 or 5 chronic kidney disease for each regimen.

SVR12, sustained virologic response at 12 weeks.